Serge Saxonov

Serge Saxonov is a visionary leader in the field of biotechnology and innovation, believing in the transformative power of technology to revolutionize the world. He envisions the 21st century as the era of biology where advancements in life sciences will bring about substantial changes.

Serge Saxonov's educational background includes a PhD in Biomedical Informatics from Stanford University and a AB in Applied Math from Harvard University, reflecting his solid foundation in academia and expertise in interdisciplinary fields.

In terms of professional experience, Serge Saxonov holds the key positions of Co-founder and CEO at 10X Genomics, showcasing his entrepreneurial spirit and leadership skills. Prior to this role, he served as the VP Applications at QuantaLife, which was later acquired by Bio-Rad in 2011. Additionally, Serge's journey includes being the First Employee, Founding Architect, and Director of R&D at the prominent genetics company, 23andMe, highlighting his extensive experience in leading innovative projects and teams.